These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4621 related articles for article (PubMed ID: 6583026)
1. Human tissue distribution of 4'-(9-acridinylamino)-methanesulfon-m-anisidide (NSC 141549, AMSA). Stewart DJ; Zhengang G; Lu K; Savaraj N; Feun LG; Luna M; Benjamin RS; Keating MJ; Loo TL Cancer Chemother Pharmacol; 1984; 12(2):116-9. PubMed ID: 6583026 [TBL] [Abstract][Full Text] [Related]
2. Tumor penetration of AMSA in man. Guo ZG; Savaraj N; Feun LG; Lu K; Stewart DJ; Luna M; Benjamin RS; Loo TL Cancer Invest; 1983; 1(6):475-8. PubMed ID: 6689404 [TBL] [Abstract][Full Text] [Related]
3. Metabolism of 4'-(9-acridinylamino)methanesulfon-m-anisidide by rat liver microsomes. Shoemaker DD; Cysyk RL; Gormley PE; DeSouza JJ; Malspeis L Cancer Res; 1984 May; 44(5):1939-45. PubMed ID: 6546898 [TBL] [Abstract][Full Text] [Related]
5. Phase II study of 4'-(9-acridinylamino) methanesulfon-m- anisidide (AMSA) in metastatic melanoma. Legha SS; Hall SW; Powell KC; Burgess MA; Benjamin RS; Gutterman JU; Bodey GP Cancer Clin Trials; 1980; 3(2):111-4. PubMed ID: 6893573 [TBL] [Abstract][Full Text] [Related]
6. 4'-(9-Acridinylamino) methanesulfon-m-anisidide (AMSA): a new drug effective in the treatment of adult acute leukemia. Legha SS; Keating MJ; Zander AR; McCredie KB; Bodey GP; Freireich EJ Ann Intern Med; 1980 Jul; 93(1):17-21. PubMed ID: 6930826 [TBL] [Abstract][Full Text] [Related]
7. High-performance liquid-chromatographic method for the determination of 4'-(9-acridinylamino)methanesulfon-m-anisidide in plasma. Jurlina JL; Paxton JW J Chromatogr; 1983 Sep; 276(2):367-74. PubMed ID: 6688811 [TBL] [Abstract][Full Text] [Related]
8. [Case of refractory acute myeloblastic leukemia who achieved complete remission by a new anti-leukemic agent, 4'-(9-acridinylamino) methanesulfon-m-anisidide (AMSA)]. Nagura E; Kawashima K; Suzuki H; Ohno R; Yamada K; Yokomaku S; Ogawa M Rinsho Ketsueki; 1983 May; 24(5):632-8. PubMed ID: 6577212 [No Abstract] [Full Text] [Related]
9. Phase II evaluation of 4'-(9-acridinylamino)-methanesulfon-m-anisidide (m-AMSA) in patients with gastric adenocarcinoma. Sordillo PP; Magill GB; Gralla RJ; Kelsen DP Am J Clin Oncol; 1982 Jun; 5(3):273-5. PubMed ID: 6896259 [TBL] [Abstract][Full Text] [Related]
10. A phase II evaluation of m-AMSA, 4'-(9-acridinylamino) methanesulfon-m-anisidide, in patients with breast cancer. Currie VE; Howard J; Wittes R Cancer Clin Trials; 1981; 4(3):249-51. PubMed ID: 6895189 [TBL] [Abstract][Full Text] [Related]
11. Protein-associated deoxyribonucleic acid strand breaks in L1210 cells treated with the deoxyribonucleic acid intercalating agents 4'-(9-acridinylamino) methanesulfon-m-anisidide and adriamycin. Zwelling LA; Michaels S; Erickson LC; Ungerleider RS; Nichols M; Kohn KW Biochemistry; 1981 Nov; 20(23):6553-63. PubMed ID: 6895473 [TBL] [Abstract][Full Text] [Related]
12. Phase II evaluation of m-AMSA (4'-(9-acridinylamino)-methanesulfon-m-anisidide) in patients with adenocarcinoma of the pancreas. Sternberg CN; Magill GB; Sordillo PP; Cheng E; Currie VE Am J Clin Oncol; 1983 Aug; 6(4):459-62. PubMed ID: 6688151 [TBL] [Abstract][Full Text] [Related]
13. Intrathecally administered m-AMSA in the rhesus monkey. Gormley P; Riccardi R; O'Neill D; Poplack D Cancer Drug Deliv; 1984; 1(2):101-7. PubMed ID: 6549572 [TBL] [Abstract][Full Text] [Related]
14. Phase II study of 4'-(9-acridinylamino)methanesulfon-m-anisidide (NSC 249992) in children with acute leukemia and lymphoma. Tan CT; Hancock C; Steinherz PG; Steinherz LJ; Sorell M; Chan KW; Mondora A; Miller DR Cancer Res; 1982 Apr; 42(4):1579-81. PubMed ID: 6895864 [TBL] [Abstract][Full Text] [Related]
16. Evaluation of 4'-(9-acridinylamino) methanesulfon-m-anisidide (m-AMSA, NSC 249992) on human tumors in nude mice. Sordillo PP; Helson L; Lesser M Cancer Clin Trials; 1980; 3(4):385-9. PubMed ID: 6893575 [TBL] [Abstract][Full Text] [Related]
17. Phase I clinical and pharmacokinetic study of 4'-(9-acridinylamino)-methanesulfon-m-anisidide in children with cancer. Rivera G; Evans WE; Dahl GV; Yee GC; Pratt CB Cancer Res; 1980 Nov; 40(11):4250-3. PubMed ID: 6258775 [TBL] [Abstract][Full Text] [Related]
18. The production of topoisomerase II-mediated DNA cleavage in human leukemia cells predicts their susceptibility to 4'-(9-acridinylamino)methanesulfon-m-anisidide (m-AMSA). Bakic M; Beran M; Andersson BS; Silberman L; Estey E; Zwelling LA Biochem Biophys Res Commun; 1986 Jan; 134(2):638-45. PubMed ID: 3004458 [TBL] [Abstract][Full Text] [Related]
19. Successful treatment of a patient with acute nonlymphoblastic leukemia (ANLL) and anthracycline cardiomyopathy with 4' (9-acridinylamino) methanesulfon-m-anisidide (AMSA). Fanucchi MP; Arlin ZA Cancer Chemother Pharmacol; 1982 Dec; 10(1):27-8. PubMed ID: 6961970 [TBL] [Abstract][Full Text] [Related]
20. Enhancement of viral growth by the antitumor drug 4'-(9-acridinylamino) methanesulfon-m-anisidide (m-AMSA). Drake S; Furlong NB; Nelson JA Biochem Pharmacol; 1983 Sep; 32(17):2615-8. PubMed ID: 6688528 [No Abstract] [Full Text] [Related] [Next] [New Search]